The Associated Press on MSN5d
EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drugThe European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
UPI News on MSN4d
Drugmaker Teva Pharmaceuticals fined $500M by European regulatorsTeva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...
Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns ...
Teva Pharmaceutical Industries Ltd. has been fined nearly €463 million ($503 million) by the European Union’s antitrust ...
Phase 3 trial results show Teva's TEV-'749 improves social functioning in adults with schizophrenia without post-injection ...
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...
GlobalData on MSN21h
Teva’s long-lasting schizophrenia injectable shines in Phase IIIData presented at Psych Congress 2024 showed improvements in social functioning and quality of life over an eight-week ...
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new patient- and physician-reported ...
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) will be announcing its earnings results before the market opens ...
The European Commission has fined Teva , the world's largest generic drugmaker, 462.6 million euros ($503 million) for abusing its dominant position to delay competition to its blockbuster multiple ...
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new, positive data on social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback